Hypogonadism

Latest

New Testosterone Replacement Therapy Approved for At-Home Self-Administration

New Testosterone Replacement Therapy Approved for At-Home Self-Administration

Xyosted carries a Boxed Warning regarding blood pressure increases that may potentially increase the risk for major adverse cardiovascular events.

Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome

Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome

This finding suggests that clinicians should monitor anxiety among individuals with testosterone deficiency and XXY.

Increased Risk for Early Gonadarche Associated With Oxandrolone Treatment

Increased Risk for Early Gonadarche Associated With Oxandrolone Treatment

Investigators examine the onset of puberty and testicular function in prepubertal boys treated with oxandrolone.

AUA: New Guidelines for Diagnosis, Management of Testosterone Deficiency

AUA: New Guidelines for Diagnosis, Management of Testosterone Deficiency

Clinicians should use a total testosterone level below 300ng/dL as a reasonable cut-off in support of the diagnosis of low testosterone.

Case Report Reveals Another Possible Side Effect of Kratom

Case Report Reveals Another Possible Side Effect of Kratom

A number of adverse events or side effects have been reported, but this is the first report of hyperprolactinemia as the result of ingestion of kratom.

Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism

Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism

Testosterone therapy is recommended in men with hypogonadism to correct symptoms of testosterone deficiency. Men who are otherwise healthy do not need to be screened for hypogonadism.

Low Sperm Count Linked to Poor Metabolic, Cardiovascular, Bone Health

Low Sperm Count Linked to Poor Metabolic, Cardiovascular, Bone Health

Researchers tested whether semen quality and reproductive function could be a marker of general health in men.

Testosterone Therapy Prescribing Practices in VA Setting

Testosterone Therapy Prescribing Practices in VA Setting

Patients attending VA clinics may experience variability in testosterone prescribing practices for hypogonadism.

Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes

Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes

At 12 years of testosterone treatment, HbA1c decreased to 5.5±0.3%.

Adherence to Topical Testosterone Therapy in Primary and Secondary Hypogonadism

Adherence to Topical Testosterone Therapy in Primary and Secondary Hypogonadism

Low adherence to topical testosterone therapy has been linked to lowered total testosterone values and poor outcomes.

Sign Up for Free e-Newsletters



CME Focus